Biofrontera (BFRI) Share-based Compensation (2021 - 2025)
Biofrontera has reported Share-based Compensation over the past 5 years, most recently at $289000.0 for Q4 2025.
- For Q4 2025, Share-based Compensation fell 3.34% year-over-year to $289000.0; the TTM value through Dec 2025 reached $728000.0, down 11.97%, while the annual FY2025 figure was $951000.0, 6.67% down from the prior year.
- Share-based Compensation for Q4 2025 was $289000.0 at Biofrontera, up from $100000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $517000.0 in Q1 2022 and troughed at $100000.0 in Q3 2022.
- A 5-year average of $227235.3 and a median of $228000.0 in 2023 define the central range for Share-based Compensation.
- Biggest five-year swings in Share-based Compensation: skyrocketed 196.9% in 2022 and later plummeted 75.0% in 2023.
- Year by year, Share-based Compensation stood at $129000.0 in 2021, then skyrocketed by 196.9% to $383000.0 in 2022, then crashed by 40.47% to $228000.0 in 2023, then surged by 31.14% to $299000.0 in 2024, then dropped by 3.34% to $289000.0 in 2025.
- Business Quant data shows Share-based Compensation for BFRI at $289000.0 in Q4 2025, $100000.0 in Q3 2025, and $100000.0 in Q2 2025.